SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
SanBio Enterprise Value: 247.52M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 247.52M |
| November 14, 2024 | 247.52M |
| November 13, 2024 | 247.52M |
| November 12, 2024 | 247.52M |
| November 11, 2024 | 247.52M |
| November 08, 2024 | 247.52M |
| November 07, 2024 | 247.52M |
| November 06, 2024 | 247.52M |
| November 05, 2024 | 247.52M |
| November 04, 2024 | 247.52M |
| November 01, 2024 | 247.52M |
| October 31, 2024 | 247.52M |
| October 30, 2024 | 247.52M |
| October 29, 2024 | 247.52M |
| October 28, 2024 | 247.52M |
| October 25, 2024 | 247.52M |
| October 24, 2024 | 247.52M |
| October 23, 2024 | 247.52M |
| October 22, 2024 | 247.52M |
| October 21, 2024 | 247.52M |
| October 18, 2024 | 247.52M |
| October 17, 2024 | 247.52M |
| October 16, 2024 | 247.52M |
| October 15, 2024 | 247.52M |
| October 14, 2024 | 247.52M |
| Date | Value |
|---|---|
| October 11, 2024 | 247.52M |
| October 10, 2024 | 247.52M |
| October 09, 2024 | 247.52M |
| October 08, 2024 | 247.52M |
| October 07, 2024 | 247.52M |
| October 04, 2024 | 247.52M |
| October 03, 2024 | 247.52M |
| October 02, 2024 | 247.52M |
| October 01, 2024 | 247.52M |
| September 30, 2024 | 247.52M |
| September 27, 2024 | 247.52M |
| September 26, 2024 | 247.52M |
| September 25, 2024 | 247.52M |
| September 24, 2024 | 247.52M |
| September 23, 2024 | 247.52M |
| September 20, 2024 | 247.52M |
| September 19, 2024 | 247.52M |
| September 18, 2024 | 247.52M |
| September 17, 2024 | 247.52M |
| September 16, 2024 | 247.52M |
| September 13, 2024 | 247.52M |
| September 12, 2024 | 247.52M |
| September 11, 2024 | 247.52M |
| September 10, 2024 | 247.52M |
| September 09, 2024 | 247.52M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
229.40M
Minimum
Oct 20 2023
1.805B
Maximum
Nov 18 2019
535.42M
Average
507.50M
Median
Nov 08 2021
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 72.21B |
| Nxera Pharma Co Ltd | 818.86M |
| PeptiDream Inc | 2.175B |
| Healios KK | 117.61M |
| AnGes Inc | 86.92M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.409M |
| Total Expenses (Quarterly) | 5.761M |
| EPS Diluted (Quarterly) | -0.108 |
| Earnings Yield | -5.47% |
| Normalized Earnings Yield | -24.04 |